Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1990-10-26
|
pubmed:abstractText |
Misaka strain was isolated as the causative agent from a patient with spotted fever group rickettsiosis in Japan by using nude mice on Awaji Island, Hyogo in September 1988. The nude mice infected with the isolate showed weakness and splenomegaly and died in two or three weeks after the infection. The cyclophosphamide-treated mice infected with the isolate died between four and seven days after the infection. The infected normal mice recovered and acquired immunity. The infected adult male guinea pigs were feverish and showed swelling and redness of the scrotum between two and eight days after the infection, and recovered. The Misaka strain was propagated well in Vero cells in tissue culture. The rickettsial particles were seen as diplobacillary and diplococcal forms growing predominantly in the cytoplasm and occasionally in the nucleus of infected cells. The serological characteristics of the Misaka strain were analyzed by the cross-immunofluorescent antibody method. The Misaka strain, the Katayama strain first isolated in Tokushima in 1987, and the representative strains of spotted fever group rickettsiae in the world; R. rickettsii Smith, R. sibirica 246, R. conorii Moroccan, R. akari MK (Kaplan), R. australis Phillips, R. montana Tick and Thai TT-118 strains were used as antigens. And immune mouse serum samples against the Misaka, Katayama, 246, Phillips and TT-118 strains were used as antisera. The result revealed that these strains showed cross-reaction and share a common antigen of spotted fever group rickettsiae. Furthermore, it became obvious that the Misaka strain and the Katayama strain have the same serotype-specific antigen different from the strains of other spotted fever group rickettsiae using Anti-Katayama monoclonal antibodies.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0387-5911
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
413-8
|
pubmed:dateRevised |
2008-12-16
|
pubmed:meshHeading |
pubmed-meshheading:2205668-Adult,
pubmed-meshheading:2205668-Animals,
pubmed-meshheading:2205668-Antibodies, Bacterial,
pubmed-meshheading:2205668-Cells, Cultured,
pubmed-meshheading:2205668-Fluorescent Antibody Technique,
pubmed-meshheading:2205668-Guinea Pigs,
pubmed-meshheading:2205668-Humans,
pubmed-meshheading:2205668-Japan,
pubmed-meshheading:2205668-Male,
pubmed-meshheading:2205668-Mice,
pubmed-meshheading:2205668-Rickettsia,
pubmed-meshheading:2205668-Rocky Mountain Spotted Fever,
pubmed-meshheading:2205668-Serotyping
|
pubmed:year |
1990
|
pubmed:articleTitle |
[The causative agent from a patient with spotted fever group rickettsiosis in Japan on Awaji Island, Hyogo].
|
pubmed:affiliation |
First Department of Internal Medicine, School of Medicine, Ehime University.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|